Related Experiment Video
Updated: May 22, 2025
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
Establishing a Structured Hypospadias Biobank Cohort for Integrated Research: Methodology, Comprehensive Database
Tariq O Abbas1,2,3, Kholoud Al-Shafai4, Asma Jamil5
1Urology Division, Sidra Medicine, Doha P.O. Box 26999, Qatar.
Insights
The Hypospadias Biobank Cohort (HBC) was established to link clinical data and biological samples, advancing research into male hypospadias etiology and improving patient care.
Area of Science:
- Urology
- Pediatric Surgery
- Genetics
Background:
- Hypospadias is a common male congenital anomaly with diagnostic and management challenges.
- Limited research exists due to a lack of integrated biobanks linking clinical, phenotypic, surgical data, and biological samples.
- The Hypospadias Biobank Cohort (HBC) was created to address this gap.
Purpose of the Study:
- To establish a comprehensive biobank cohort for hypospadias research.
- To facilitate a deeper understanding of hypospadias etiology.
- To improve patient outcomes through advanced research.
Main Methods:
- Multi-phase enrollment of participants from specialized clinics (April 2022 - September 2024).
- Collection of biological samples (blood, tissue) under standardized protocols with informed consent.
- Systematic recording and integration of detailed clinical data into a robust database.
Main Results:
- The cohort includes diverse patients with varying hypospadias severity and associated anomalies.
- Correlations identified between hypospadias severity and postoperative complications.
- Preliminary analyses suggest potential biomarkers for hypospadias severity and recovery.
Conclusions:
- The HBC is a novel resource providing insights into the hypospadias spectrum.
- It enables refinement of classification systems and development of evidence-based surgical techniques.
- The HBC supports personalized care strategies and improved long-term outcomes for hypospadias patients.
Abstract:
Background/Objectives: Hypospadias, a common congenital anomaly in males, presents significant challenges in diagnosis, management, and long-term care. Despite its prevalence, research into the condition has been hampered by the lack of integrated biobank cohorts linking clinical, phenotypic, and surgical data with biological samples. This study aimed to establish the Hypospadias Biobank Cohort (HBC), a comprehensive resource designed to advance the understanding of hypospadias etiology and improve patient outcomes. Methods: The HBC was developed using a multi-phase approach, enrolling participants from specialized clinics between April 2022 and September 2024. Biological samples (blood and tissue) were collected under standardized protocols following informed consent. Detailed clinical data, including hypospadias severity, associated anomalies, and surgical outcomes, were systematically recorded and integrated into a robust database to support translational research. Results: The cohort included a diverse group of patients with varying severity of hypospadias, many of whom also presented with associated anomalies. Surgical outcomes were tracked, revealing important correlations between severity and postoperative complications. Preliminary biological analyses identified potential biomarkers associated with hypospadias severity and recovery. The full details of these results will be presented in a separate publication. The comprehensive database is continuously updated with longitudinal follow-up data, supporting future translational research. Conclusions: The Hypospadias Biobank Cohort represents a groundbreaking resource for translational research, offering unprecedented insights into the clinical and phenotypic spectrum of hypospadias. By enabling the refinement of classification systems and the development of evidence-based surgical techniques, the HBC has the potential to transform the management of this congenital condition. Ongoing research leveraging the HBC will further unravel the complex interplay among clinical presentation, surgical interventions, and patient outcomes, paving the way for personalized care strategies and improved long-term results.
